XML 14 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Data (Tables)
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables reflects the segment recast for the prior-year period and reconciles Adjusted EBITDA for reportable segments to consolidated net income (loss) attributable to Covetrus:
 
 
At and For the Three Months Ended September 30, 2019
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
543

 
$
384

 
$
94

 
$

 
$
(3
)
 
$
1,018

Adjusted EBITDA
 
$
39

 
$
15

 
$
5

 
$
(10
)
 
$

 
$
49

Total assets
 
$
2,848

 
$
622

 
$
121

 
$
1,108

 
$
(1,371
)
 
$
3,328

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Loss Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net loss attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
(906
)
Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
41

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
16

Less: Income tax benefit
 
 
 
 
 
 
 
 
 
 
 
(60
)
Earnings before interest, taxes, depreciation and amortization
 
 
 
 
 
 
 
(909
)
Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
10

Plus: Formation of Covetrus
 
 
 
 
 
 
 
 
 
 
 
14

Plus: IT infrastructure
 
 
 
 
 
 
 
 
 
 
 
2

Plus: Goodwill impairment
 
 
 
 
 
 
 
 
 
 
 
939

Less: Minority interest in goodwill impairment
 
(3
)
Less: Other income items
 
 
 
 
 
 
 
 
 
 
 
(4
)
Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
49

 
 
At and For the Three Months Ended September 30, 2018
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
479

 
$
351

 
$
95

 
$

 
$
(2
)
 
$
923

Adjusted EBITDA
 
$
42

 
$
16

 
$
5

 
$
(10
)
 
$

 
$
53

Total assets
 
$
1,310

 
$
688

 
$
196

 
$
12

 
$
(4
)
 
$
2,202

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Income Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net income attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
16

Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
16

Plus: Income tax expense
 
 
 
 
 
 
 
19

Earnings before interest, taxes, depreciation and amortization
 
 
 
 
 
 
 
51

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
$
2

Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
53


 
 
For the Nine Months Ended September 30, 2019
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
1,592

 
$
1,114

 
$
270

 
$

 
$
(8
)
 
$
2,968

Adjusted EBITDA
 
$
117

 
$
50

 
$
14

 
$
(27
)
 
$

 
$
154

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Loss Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net loss attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
(929
)
Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
113

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
41

Less: Income tax benefit
 
 
 
 
 
 
 
 
 
 
 
(60
)
Earnings before interest, taxes, depreciation and amortization
 
 
 
 
 
 
 
(835
)
Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
35

Plus: Formation of Covetrus
 
 
 
 
 
 
 
 
 
 
 
27

Plus: Carve-out operating expenses
 
 
 
 
 
 
 
 
 
 
 
5

Plus: IT infrastructure
 
 
 
 
 
 
 
 
 
 
 
4

Plus: Goodwill impairment
 
 
 
 
 
 
 
 
 
 
 
939

Less: Minority interest in goodwill impairment
 
(3
)
Less: Other income items
 
 
 
 
 
 
 
 
 
 
 
(18
)
Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
154

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended September 30, 2018
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
1,479

 
$
1,113

 
$
291

 
$

 
$
(8
)
 
$
2,875

Adjusted EBITDA
 
$
121

 
$
56

 
$
16

 
$
(29
)
 
$

 
$
164

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Income Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net income attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
67

Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
49

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
1

Plus: Income tax expense
 
 
 
 
 
 
 
 
 
 
 
33

Earnings before interest, taxes, depreciation and amortization
 
 
 
 
 
 
 
150

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
6

Plus: Restructuring costs
 
 
 
 
 
 
 
 
 
 
 
8

Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
164